Patent ID: 11866425
Assignee: PFIZER INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 1:
2. A method for treating Type II diabetes mellitus, early-onset Type 2 diabetes (EOD), conditions of impaired glucose tolerance (IGT), conditions of impaired fasting plasma glucose, metabolic acidosis, metabolic syndrome, syndrome X, hyperglycemia, hyperinsulinemia, insulin resistance, or impaired glucose metabolism, in humans comprising the step of administering to a human in need of such treatment a therapeutically effective amount of a compound according to Formula (I) or a pharmaceutically acceptable salt of said compound;, wherein
D1 and D2 are each independently N or CH;
R1 is H, or (C1-C2)alkyl optionally substituted with one or two substituents each independently selected from fluoro and (C3-C6)cycloalkyl,
R2 is H or fluoro;
R3 is,, R4 is H, cyano, or (C1-C4)alkyl optionally substituted with one or two substituents each independently selected from —OH and —S(O)2R6;
R5 is H or —OH; and
R6 is (C1-C4)alkyl.